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Following publication of our article [1] we have noticed the
following error in nomenclature:
All four polymorphisms studied were referred to as
FCRL3-169*C/T.
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Table 1
Genotype frequencies of Fc receptor-like 3 (FCRL3) single nucleotide polymorphisms in rheumatoid arthritis cases, in controls and
in subgroups
Single nucleotide polymorphism Controls Cases Two-copy shared epitope allelesb Rheumatoid factor-positive a, c
Controls Cases
FCRL3-169*C/T (fclr3_3, rs7528684)
T/T 595 (28.7) 324 (30.4) 45 (36.9) 71 (32.0) 324 (30.4)
C/T 1055 (50.9) 524 (49.2) 52 (42.6) 103 (46.4) 524 (49.2)
C/C 423 (20.4) 217 (20.4) 25 (20.5) 48 (21.6) 217 (20.4)
P value 0.57 0.69 0.57
FCRL3-110*C/T (fclr3_4, rs11264799)
1/1 258 (53.3) 404 (53.1) 13 (50.0) 132 (52.6) 404 (53.1)
1/2 190 (39.3) 296 (38.9) 10 (38.5) 95 (37.8) 296 (38.9)
2/2 36 (7.4) 61 (8.0) 3 (11.5) 24 (9.6) 61 (8.0)
P value 0.93 0.94 0.93
FCRL3+358*C/G (fclr3_5, rs945635)
1/1 123 (27.9) 209 (28.4) 9 (36.0) 64 (27.3) 209 (28.4)
1/2 200 (45.3) 362 (49.3) 12 (48.0) 116 (49.6) 362 (49.3)
2/2 118 (26.8) 164 (22.3) 4 (16.0) 54 (23.1) 164 (22.3)
P value 0.46 0.57 0.46
FCRL3+1370*A/G (fclr3_6, rs3761959)
1/1 124 (26.3) 209 (27.8) 8 (30.8) 65 (27.1) 209 (27.8)
1/2 220 (46.7) 370 (49.3) 12 (46.1) 120 (50.0) 370 (49.3)
2/2 127 (27.0) 172 (22.9) 6 (23.1) 55 (22.9) 172 (22.9)
P value 0.28 0.91 0.28
Data presented as n (%). aComparison group = all controls. bSubgroup stratified by two copies of shared epitope alleles. cSubgroup stratified by
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FCRL3-169*C/T (fclr3_3, rs7528684) is correctly named.
FCRL3-169*C/T (fclr3_4, rs11264799) should be FCRL3-
110*C/T (fclr3_4, rs11264799).
FCRL3-169*C/T (fclr3_5, rs945635) should be
FCRL3+358*C/G (fclr3_5, rs945635).
FCRL3-169*C/T (fclr3_6, rs3761959) should be
FCRL3+1370*A/G (fclr3_6, rs3761959).
Thus, Table 1 should appear as shown above.
Within ‘Patients and methods’, the paragraph ‘Poly-
morphisms selected’ should read as follows:
Four SNPs – FCRL3-169*C/T (fclr3_3, rs7528684), FCRL3-
110*C/T (fclr3_4, rs11264799), FCRL3+358*C/G (fclr3_5,
rs945635) and FCRL3+1370*A/G (fclr3_6, rs3761959) –
were initially selected for investigation because they had all
been associated with RA in the Japanese population on
single-point analysis, because the SNPs formed a haplotype
associated with RA and because the most probable disease
causal SNP (FCRL3-169*C/T (fclr3_3, rs7528684)) was
included [7].
The second paragraph of ‘Results’ should read as follows:
No deviation from Hardy–Weinberg expectations was observed
for any of the SNPs in either cases or controls. Interim analysis
after genotyping a subset of the total cohort revealed that
extensive linkage disequilibrium was present across the four
SNPs tested. Indeed, the D′ value between all the SNPs was
0.98 while the correlation between SNPs FCRL3-169*C/T
(fclr3_3, rs7528684), FCRL3+358*C/G fclr3_5 (rs945635)
and FCRL3+1370*A/G fclr3_6 (rs3761959) was also 0.98 in
this sample. The correlation between these SNPs and FCRL3-
110*C/T fclr3_4 (rs11264799) was 0.6 or greater, reflecting
the difference in allele frequency of this SNP compared with the
others. Hence, genotyping of all four SNPs was unnecessary
and, in the remaining samples, only the putative disease causal
polymorphism was genotyped.
The above changes in no way affect the conclusions of the
study.
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